HEMHORIZON Trademark

Trademark Overview


On Friday, January 7, 2022, a trademark application was filed for HEMHORIZON with the United States Patent and Trademark Office. The USPTO has given the HEMHORIZON trademark a serial number of 97207988. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by Pfizer Inc.. The HEMHORIZON trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical information services, namely, providing medical information on the topic of hemophilia, the treatment of hemophilia and gene therapies for the treatment of hemophilia; online medical information services, namely, providing medical information on the topic of hemophilia, the treatment of hemophilia and gene therapies for the treatment of hemophilia
hemhorizon

General Information


Serial Number97207988
Word MarkHEMHORIZON
Filing DateFriday, January 7, 2022
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7140642
Registration DateTuesday, August 15, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2022

Trademark Statements


Pseudo MarkHEM HORIZON; HEMOPHILIA HORIZON
Goods and ServicesMedical information services, namely, providing medical information on the topic of hemophilia, the treatment of hemophilia and gene therapies for the treatment of hemophilia; online medical information services, namely, providing medical information on the topic of hemophilia, the treatment of hemophilia and gene therapies for the treatment of hemophilia

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 13, 2022
Primary Code044
First Use Anywhere DateSaturday, April 30, 2022
First Use In Commerce DateSaturday, April 30, 2022

Trademark Owner History


Party NamePfizer Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001-219

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Thursday, July 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, July 12, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 12, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, June 26, 2023USE AMENDMENT FILED
Wednesday, July 12, 2023SOU EXTENSION 1 GRANTED
Monday, June 26, 2023SOU EXTENSION 1 FILED
Monday, July 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023TEAS STATEMENT OF USE RECEIVED
Monday, March 27, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 27, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 27, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 27, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022ASSIGNED TO EXAMINER
Thursday, January 13, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 11, 2022NEW APPLICATION ENTERED